The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: lidocaine     Quarter: 2016Q3

Total Drug/Injury Combinations: 659     Number of Pages: 33

DRUGNAME PT EventCount
LIDOCAINE HCL Arthritis infective 1 view events
LIDOCAINE HCL Arthrodesis 1 view events
LIDOCAINE HCL Arthropathy 1 view events
LIDOCAINE HCL Back pain 1 view events
LIDOCAINE HCL Bacterial infection 1 view events
LIDOCAINE HCL Burning sensation 1 view events
LIDOCAINE HCL Circulatory collapse 1 view events
LIDOCAINE HCL Coma 1 view events
LIDOCAINE HCL Death 1 view events
LIDOCAINE HCL Diplopia 1 view events
LIDOCAINE HCL Discomfort 1 view events
LIDOCAINE HCL Disease recurrence 1 view events
LIDOCAINE HCL Drug administration error 1 view events
LIDOCAINE HCL Drug effect incomplete 1 view events
LIDOCAINE HCL Drug ineffective for unapproved indication 1 view events
LIDOCAINE HCL Drug level increased 1 view events
LIDOCAINE HCL Electrocardiogram QRS complex prolonged 1 view events
LIDOCAINE HCL Endocrine disorder 1 view events
LIDOCAINE HCL Exposure during pregnancy 1 view events
LIDOCAINE HCL Feeling drunk 1 view events

Total Drug/Injury Combinations: 659     Number of Pages: 33

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)